These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 12875980)

  • 1. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
    Hishikawa N; Niwa J; Doyu M; Ito T; Ishigaki S; Hashizume Y; Sobue G
    Am J Pathol; 2003 Aug; 163(2):609-19. PubMed ID: 12875980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.
    Ito T; Niwa J; Hishikawa N; Ishigaki S; Doyu M; Sobue G
    J Biol Chem; 2003 Aug; 278(31):29106-14. PubMed ID: 12750386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders.
    Ishigaki S; Hishikawa N; Niwa J; Iemura S; Natsume T; Hori S; Kakizuka A; Tanaka K; Sobue G
    J Biol Chem; 2004 Dec; 279(49):51376-85. PubMed ID: 15456787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity.
    Niwa J; Ishigaki S; Hishikawa N; Yamamoto M; Doyu M; Murata S; Tanaka K; Taniguchi N; Sobue G
    J Biol Chem; 2002 Sep; 277(39):36793-8. PubMed ID: 12145308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.
    Sampathu DM; Giasson BI; Pawlyk AC; Trojanowski JQ; Lee VM
    Am J Pathol; 2003 Jul; 163(1):91-100. PubMed ID: 12819014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
    Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
    Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity.
    Ishigaki S; Niwa J; Yamada S; Takahashi M; Ito T; Sone J; Doyu M; Urano F; Sobue G
    Neurobiol Dis; 2007 Feb; 25(2):331-41. PubMed ID: 17157513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of nuclear receptor subfamily 4, group A, member 3 (NR4A3) in Lewy body disease and multiple system atrophy.
    Kon T; Miki Y; Tanji K; Mori F; Tomiyama M; Toyoshima Y; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
    Neuropathology; 2015 Dec; 35(6):503-9. PubMed ID: 26096603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
    Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.
    Pountney DL; Chegini F; Shen X; Blumbergs PC; Gai WP
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):74-9. PubMed ID: 15882793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.